FLT4 and non-small cell lung carcinoma: Collectively, these findings suggest that HN-N07 may be a potential inhibitor of the BIRC5/HIF1A/FLT4 oncogenic signaling pathway in NSCLC (Table 2, Table 3 and Table 4).